• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Phase III Trial Results For Hypertension Pill Published In Lancet

    18 Oct 2024 //

    GLOBENEWSWIRE

    George Medicines` Triple Pill for Hypertension Highlighted at Congress

    24 Sep 2024 //

    GLOBENEWSWIRE

    George Medicines Posts Positive Results For Triple-Combo Blood Pressure Drug

    31 Aug 2024 //

    FIERCE PHARMA

    George Medicines Files NDA For Novel Hypertension Treatment

    06 Aug 2024 //

    GLOBENEWSWIRE

    George Medicines Appoints Mark Mallon as CEO & Director

    29 Apr 2024 //

    GLOBENEWSWIRE

    George Medicines completes recruitment of first PIII trial investigating GMRx2

    12 Jul 2023 //

    GLOBENEWSWIRE

    George taps Medisante tech for decentralised blood pressure trial

    16 Sep 2022 //

    PHARMAPHORUM

    George Medicines provides single-pill triple combO candidate for hypertension

    07 Sep 2022 //

    GLOBENEWSWIRE

    George Medicines advances triple combination candidate GMRx4 into PII study

    20 Jul 2022 //

    GLOBENEWSWIRE

    Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill

    17 Jan 2022 //

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.